Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Michal, Hawranek"'
Autor:
Krzysztof Wilczek, Michal Hawranek, Wojciech Wojakowski, Piotr Chodór, Michal Zembala, Pawel Buszman, Andrzej Bochenek, Marek Deja, Maciej Dyrbus, Daniel Ciesla, Zbigniew Kalarus, Mariusz Gasior, Marian Zembala
Publikováno v:
Anatolian Journal of Cardiology, Vol 26, Iss 3, Pp 172-179 (2022)
Background: Data concerning the comparison between transcatheter aortic valve implantation and surgical aortic valve replacement in a real-world setting are scarce and in Central and Eastern Europe no such data exist. In this study, we aimed at analy
Externí odkaz:
https://doaj.org/article/529ee8b3b09a4f108d5c14bf7ae73599
Autor:
Adam Kowalówka, Tomasz Roleder, Pawel Gasior, Agnieszka Pregowska, Grzegorz Smolka, Michal Hawranek
Publikováno v:
Advances in Interventional Cardiology. 15:505-514
Autor:
Anna, Kurek, Mateusz, Tajstra, Elzbieta, Gadula-Gacek, Piotr, Buchta, Michal, Skrzypek, Lukasz, Pyka, Michal, Wasiak, Malgorzata, Swietlinska, Michal, Hawranek, Lech, Polonski, Mariusz, Gasior, Jedrzej, Kosiuk
Publikováno v:
Journal of cardiovascular electrophysiology. 28(4)
Randomized controlled trials demonstrate that remote monitoring (RM) of implantable cardioverter-defibrillators (ICDs) and cardiac resynchronization therapy devices (CRT-Ds) may improve quality of care and prognosis in heart failure (HF) patients. Ho
Autor:
Michal, Hawranek, Mariusz, Gasior, Marek, Gierlotka, Krzysztof, Wilczek, Andrzej, Lekston, Bozena, Szygula-Jurkiewicz, Artur, Spatuszko, Lech, Polonski
Publikováno v:
The Journal of invasive cardiology. 22(5)
Today's knowledge concerning the progression of coronary artery disease (CAD) is mainly derived from randomised clinical studies performed in patients with stable CAD. Data on atherosclerosis progression (AP) after myocardial infarction are limited.